C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CGC Canadian LP

Canopy Growth

NASDAQ · CGC

One of the original Canadian LPs. Formerly backed by Constellation Brands with US expansion through Acreage Holdings.

$0.92
-0.08%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
53/100 composite
Fundamentals58
Regulatory73
Market40
Editorial30
Composite · trailing 12 months

The model outputs a Neutral rating for Canopy Growth, scoring 53/100 at conviction 2 of 5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 73 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.

Pillar-level, the record reads as reported revenue growth of 9.6 percent year over year, an operating margin of -24.7 percent, gross margin of 28.0 percent, a market cap near 436 million, a filing cadence of 4 regulator events in the trailing 90 days, a jurisdictional posture reading of 80. Each of those data points tethers the Neutral conclusion to observable evidence. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets Canopy Growth be lined up against the global cannabis coverage universe on identical inputs, with refresh cadence tied directly to primary-source ingest.

Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 73. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
1 HERSHEY DRIVE, SMITH FALLS, A6, K7A0A8
Phone
855-558-9333
CEO
Luc Mo***u
CFO
Thomas St***t
SEC CIK
1737927
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$435.5M
Enterprise value
$346.8M
Price to book
0.84
Price to sales
1.53
EV / EBITDA
11014.10
Revenue (TTM)
$284.6M
Gross profit (TTM)
$79.5M
EBITDA
$-26.8M
Operating margin
-24.7%
Profit margin
-92.4%
Rev growth YoY
9.6%
Return on equity
-44.7%
Return on assets
-3.9%
EPS (TTM)
$-0.62
EPS est. current year
$-0.47
Wall St. target price
$1.23
Shares outstanding
422.2M
Insider ownership
0.2%
Institutional ownership
7.9%
Beta
2.42
Full-time employees
1,128
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Canopy Growth (CGC)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Canopy Growth (CGC), a cannabis-sector equity listed on NASDAQ in the Canadian LP category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $1.57.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss, insider selling. (3 bullish signals, 4 bearish signals.)

One of the original Canadian LPs. Formerly backed by Constellation Brands with US expansion through Acreage Holdings.

Latest price: $0.92 (-0.08%) on NASDAQ.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CGC are maintained by Cannabis Investor News and refreshed throughout the trading day.